Nifurtoinol

Chemical compound
  • J01XE02 (WHO)
Pharmacokinetic dataExcretionRenal (40–50% within the first 12 hours)Identifiers
  • 3-(hydroxymethyl)-1-{[(1E)-(5-nitro-2-furyl)
    methylene]amino}imidazolidine-2,4-dione
CAS Number
  • 1088-92-2 checkY
PubChem CID
  • 9571062
ChemSpider
  • 7845528 ☒N
UNII
  • 980688H13O
KEGG
  • D07243 checkY
ChEBI
  • CHEBI:88255 ☒N
CompTox Dashboard (EPA)
  • DTXSID30148747 Edit this at Wikidata
ECHA InfoCard100.012.842 Edit this at WikidataChemical and physical dataFormulaC9H8N4O6Molar mass268.185 g·mol−13D model (JSmol)
  • Interactive image
  • C1C(=O)N(C(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-])CO
InChI
  • InChI=1S/C9H8N4O6/c14-5-11-7(15)4-12(9(11)16)10-3-6-1-2-8(19-6)13(17)18/h1-3,14H,4-5H2/b10-3+ ☒N
  • Key:UIDWQGRXEVDFCA-XCVCLJGOSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Nifurtoinol (rINN, trade name Urfadyn) is a nitrofuran-derivative antibiotic used in the treatment of urinary tract infections.[citation needed]

It is also known as "hydroxymethylnitrofurantoin".[1]

References

  1. ^ Stricker BH, Blok AP, Claas FH, Van Parys GE, Desmet VJ (1988). "Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases". Hepatology. 8 (3): 599–606. doi:10.1002/hep.1840080327. PMID 3371877.
  • v
  • t
  • e
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins


Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e